Centre should intervene when patented medicines are sold at exorbitant rate: Kerala HC
The Kerala High Court ruled that the Central government can manufacture and sell patented medicines at lower prices to the public, especially for underprivileged patients. This decision follows a petition aimed at addressing exorbitant rates for essential medications. The court emphasized the need for government intervention to ensure affordable access to healthcare for all citizens.